Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma. [electronic resource]
- BMC cancer Dec 2007
- 224 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't